Bio Protocol price jumps 70% amid v2 upgrade and staking launch

Bio Protocol, the financial layer of the decentralized science platform, has seen its native token surge 70% in the past 24 hours as momentum from its v2 upgrade and rewards launch fuels bullish sentiment.

Summary

• Bio Protocol token’s price pumped nearly 70% to hit highs of $0.098
• Gains came as altcoins bounced, with Bio Protocol also rising amid network activity and rewards launch.

The Bio Protocol (BIO) token pumped nearly 70% as major altcoins bounced, with the decentralized biotech funding and research project’s gains coming amid key network developments.

BIO traded at lows of $0.059 on Aug. 7, but went vertical to hit $0.098 as Bitcoin (BTC) touched highs above $116k and Ethereum (ETH) broke the $3,800 mark. Gains see Bio Protocol rank as the best performing DeSci token in the past 24 hours, outpacing OriginTrail, AlchemistAI and ResearchCoin.

BIO is now trading at its highest level since May 2025 and has attracted significant attention, with daily volume spiking 1,400% to over $288 million. BIO reached an all-time high of $0.92 in January 2025.

You might also like: MAMO crashes after Coinbase debut despite 120% weekly surge — is the run out of steam?

Bio Protocol gains amid v2 and exchange listing momentum

Activity for the protocol has ramped up after Coinbase announced listing support in late July and the unveiling of Bio Protocol’s v2 launch. Making it hot for BIO is also the Desci project’s BioXP points and rewards debut.

While Bio Protocol v1 enabled one-time, large fundraising events for BioDAOs, v2 introduces a model that supports smaller, experimental launches. It also integrates staking incentives, allowing users to earn rewards while backing scientific innovation onchain.

On Aug. 7, Bio Protocol announced staking for its token BIO and BioDAO tokens was now live on the Ethereum mainnet. This follows a notable 25 million BIO staked on Base within days of its launch.

Institutional interest

Interest in the rewards program appears to be just part of the story. Bio Protocol is attracting broader institutional attention amid growing momentum in the decentralized science sector.

The project attracted investment from Binance Labs in November 2024 and raised more than $64.4 million via a public sale in January 2025 at the fully diluted valuation of $219.12 million.

Bio Protocol’s token went live on BNB Chain and Ethereum on Jan. 3, before expanding to Solana via the Wormhole cross-chain bridge as the project debuted its launchpad and liquidity protocol.

You might also like: Bitcoin ETFs end 4-day bleeding streak with $92M inflows, can BTC follow?

Source